A Phase II international multicenter randomized study testing the effect on survival of prolonging platinum-free interval in patients with ovarian cancer recurring between 6 and 12 months after previous platinum based chemotherapy.
Study sites
- AZ Damiaan Oostende
- AZ Groeninge, Kortrijk
- AZ Klina, Brasschaat
- AZ Nikolaas, St-Niklaas
- AZ St. Maarten Duffel, Duffel
- Clinique Ste-Elisabeth, Namur
- Clinique St. Joseph, Liège
- CHR Citadelle, Liège
- CHU Tivoli, La Louvière
- Imeldaziekenhuis Bonheiden
- UZ Leuven, Leuven